sickle cell renal involvement 2

Upload: poyton

Post on 30-May-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Sickle Cell Renal Involvement 2

    1/21

    Sickle Cell Nephropathy

    Caroline Booth

    Paediatric Nephrology

  • 8/14/2019 Sickle Cell Renal Involvement 2

    2/21

    Powars et al (1991)

    25 yr observational study

    725 patients most observed from birth or

    early childhood 4% developed renal failure at a median age

    of 23 yrs

    Survival once in renal failure 4yrs Study increased and extended by 15yrs

    12% patients developed ESRF by 37yrs

  • 8/14/2019 Sickle Cell Renal Involvement 2

    3/21

    Renal involvement

    More frequent in HbSS than HbSC

    Exception renal medullary carcinoma

    Develop nephron loss and compensatoryhypertrophy

    Prevalence of proteinuria increases with age,estimated at 20-30%.

    Decreased renal function 5-25% Renal infarcts and papillary necrosis 30-40% in

    radiological studies

  • 8/14/2019 Sickle Cell Renal Involvement 2

    4/21

    Pathologies

    Papillary necrosis

    Glomerular enlargement

    Focal segmental glomerulosclerosis

    Type 1 membranoproliferative

    glomerulonephritis without immune

    complex deposits

  • 8/14/2019 Sickle Cell Renal Involvement 2

    5/21

  • 8/14/2019 Sickle Cell Renal Involvement 2

    6/21

  • 8/14/2019 Sickle Cell Renal Involvement 2

    7/21

    Tubular defects

    Concentrating defect irreversible by age

    15yrs

    incomplete type IV renal tubular acidosis

    Impaired potassium secretion

    Hyponatraemia in crisesIncreased tubular reabsorption of phosphate &

    b-microglobulin and increased secretion of uric

    acid and creatinine

  • 8/14/2019 Sickle Cell Renal Involvement 2

    8/21

    Renal haemodynamics

    Increased glomerular filtration rate

    Increased renal plasma blood flow

    Biopsy increase in glomerular size - 87% larger

    May be mediated by increased production of prostaglandins,

    prostacyclin,

    nitirc acid

  • 8/14/2019 Sickle Cell Renal Involvement 2

    9/21

  • 8/14/2019 Sickle Cell Renal Involvement 2

    10/21

    FSGS

    Oxidative stress ischemic reperfusion

    injury with associated chronic inflammatory

    response

    Hyperfiltration very common lesion in

    Sickle cell disease

    Proteinuria

    ?ongoing vascular endothelial damage

  • 8/14/2019 Sickle Cell Renal Involvement 2

    11/21

    Issues in Paediatrics

    High prevalance of proteinuria (P) in

    children 19 -26% increasing with age

    Microalbuminuria (MA) 46% by teens

    Some papers have shown correlation with

    degree of anaemia (Alvarez et al 2008)

    Others do not (Guasch et al 2008)

  • 8/14/2019 Sickle Cell Renal Involvement 2

    12/21

    Diabetes

    Strong association with hyperfiltrationmicroalbuminuria and renal impairment

    Long term studies strong associationbetween progression of microalbuminuriaand future development of renal impairment

    These studies are not available for HBSS Alvarez et al (2008) showed no progressionbut retrospective and short term

  • 8/14/2019 Sickle Cell Renal Involvement 2

    13/21

    Monitoring

    Progression to renal impairment uncertain

    Need to monitor in all children

    Recommend annual urinary albumin

    measurements

    Blood pressure review should be low

    hypertension poor prognostic indicator

    Renal function ?best way

  • 8/14/2019 Sickle Cell Renal Involvement 2

    14/21

    Early Markers

    Voskaridou et al 2006

    Studied cystatin C, NAG, b2-microglobulin,

    creatinine clearance

    Cystatin C and serum b2- microglobulin

    showed strong correlation with creatinine

    clearance and age

    NAG positively correlated with proteinuria

  • 8/14/2019 Sickle Cell Renal Involvement 2

    15/21

    Intervention

    Optimise sickle cell management

    NSAIDS isolated reports no long term

    benefit Immunosuppressive drugs as above

    Hydroxyurea Shown to decrease

    proteinuria short term ACE1 short term use reduce proteinuria but

    with cessation worsening

  • 8/14/2019 Sickle Cell Renal Involvement 2

    16/21

    What we are doing

    Initially looking at a cross section of

    patients

    The first groups were transfusion dependent

    patients

    Performed GFRs and measuring true

    creatinine, ADMA and SDMA,NAG, RBPand looking for microalbuminuria

  • 8/14/2019 Sickle Cell Renal Involvement 2

    17/21

    Plasma creatinine v Inutest GFR

    y = -0.1478x + 58.373

    R2

    = 0.1325

    0

    10

    20

    30

    40

    50

    60

    70

    0 20 40 60 80 100 120 140 160 180 200

    Inutest GFR (ml/min/1.73m2)

    Plasmacreatin

    ine(mol/l)

  • 8/14/2019 Sickle Cell Renal Involvement 2

    18/21

    eGFR v Inutest GFR

    y = 0.7323x + 51.911

    R2

    = 0.2888

    0

    50

    100

    150

    200

    250

    0 20 40 60 80 100 120 140 160 180 200

    Inutest GFR (ml/min/1.73m2)

    eGFR

    (ml/m

    in/1.7

    3m2

  • 8/14/2019 Sickle Cell Renal Involvement 2

    19/21

    Figure 2. Plasma SDMA v GFR

    y = 20.563x-0.7998

    R2

    = 0.8888

    0.00

    1.00

    2.00

    3.00

    4.00

    5.00

    6.00

    0 20 40 60 80 100 120 140

    GFR (ml/min/1.73m2)

    SDMA(m

    ol/l)

  • 8/14/2019 Sickle Cell Renal Involvement 2

    20/21

    Plasma SDMA v Inutest GFR

    y = -0.0029x + 0.7951

    R2

    = 0.49970

    0.1

    0.2

    0.3

    0.4

    0.5

    0.6

    0.7

    0 20 40 60 80 100 120 140 160 180 200

    Inutest GFR (ml/min/1.73m2)

    PlasmaSDMA(mol/l

  • 8/14/2019 Sickle Cell Renal Involvement 2

    21/21

    Future

    Big questions remain as

    When to start treatment

    What with

    How long for